New midazolam hydrochloride crystal form and preparation method thereof
The invention relates to the field of medicine crystal forms, in particular to midazolam hydrochloride crystal forms III and VI and a preparation method thereof. The obtained crystal form III of the compound shown in the formula (I) has good physical stability and chemical stability, the used crysta...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WANG YING CHEN HONG ZENG XUEYAO HUANG CUI GU HUIKE |
| description | The invention relates to the field of medicine crystal forms, in particular to midazolam hydrochloride crystal forms III and VI and a preparation method thereof. The obtained crystal form III of the compound shown in the formula (I) has good physical stability and chemical stability, the used crystallization solvent is low in toxicity and residue, and the crystal form III is more suitable for large-scale production and amplification.
本申请涉及药物晶型领域，具体涉及盐酸咪达唑仑晶型Ⅲ、Ⅵ及其制备方法。本发明所得到的式(I)化合物的晶型Ⅲ具有较好的物理稳定性和化学稳定性，并且所用结晶溶剂低毒低残留，更适合于大规模生产放大。 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN116041351A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN116041351A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN116041351A3</originalsourceid><addsrcrecordid>eNqNyjsKAjEQANA0FqLeYTyAYFi1l8VPtZX9MiQTEkgyYTIg6-ltPIDVa97aPCZ6Q0keP5yxQFy8sIuZJXkCJ0tXzBBYCmD10IQaCmriCoU0sgeNJMRha1YBc6fdz43Z32-v8XmgxjP1ho4q6TxO1l6OJzuc7XX453wBrno0bg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>New midazolam hydrochloride crystal form and preparation method thereof</title><source>esp@cenet</source><creator>WANG YING ; CHEN HONG ; ZENG XUEYAO ; HUANG CUI ; GU HUIKE</creator><creatorcontrib>WANG YING ; CHEN HONG ; ZENG XUEYAO ; HUANG CUI ; GU HUIKE</creatorcontrib><description>The invention relates to the field of medicine crystal forms, in particular to midazolam hydrochloride crystal forms III and VI and a preparation method thereof. The obtained crystal form III of the compound shown in the formula (I) has good physical stability and chemical stability, the used crystallization solvent is low in toxicity and residue, and the crystal form III is more suitable for large-scale production and amplification.
本申请涉及药物晶型领域，具体涉及盐酸咪达唑仑晶型Ⅲ、Ⅵ及其制备方法。本发明所得到的式(I)化合物的晶型Ⅲ具有较好的物理稳定性和化学稳定性，并且所用结晶溶剂低毒低残留，更适合于大规模生产放大。</description><language>chi ; eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230502&DB=EPODOC&CC=CN&NR=116041351A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230502&DB=EPODOC&CC=CN&NR=116041351A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WANG YING</creatorcontrib><creatorcontrib>CHEN HONG</creatorcontrib><creatorcontrib>ZENG XUEYAO</creatorcontrib><creatorcontrib>HUANG CUI</creatorcontrib><creatorcontrib>GU HUIKE</creatorcontrib><title>New midazolam hydrochloride crystal form and preparation method thereof</title><description>The invention relates to the field of medicine crystal forms, in particular to midazolam hydrochloride crystal forms III and VI and a preparation method thereof. The obtained crystal form III of the compound shown in the formula (I) has good physical stability and chemical stability, the used crystallization solvent is low in toxicity and residue, and the crystal form III is more suitable for large-scale production and amplification.
本申请涉及药物晶型领域，具体涉及盐酸咪达唑仑晶型Ⅲ、Ⅵ及其制备方法。本发明所得到的式(I)化合物的晶型Ⅲ具有较好的物理稳定性和化学稳定性，并且所用结晶溶剂低毒低残留，更适合于大规模生产放大。</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyjsKAjEQANA0FqLeYTyAYFi1l8VPtZX9MiQTEkgyYTIg6-ltPIDVa97aPCZ6Q0keP5yxQFy8sIuZJXkCJ0tXzBBYCmD10IQaCmriCoU0sgeNJMRha1YBc6fdz43Z32-v8XmgxjP1ho4q6TxO1l6OJzuc7XX453wBrno0bg</recordid><startdate>20230502</startdate><enddate>20230502</enddate><creator>WANG YING</creator><creator>CHEN HONG</creator><creator>ZENG XUEYAO</creator><creator>HUANG CUI</creator><creator>GU HUIKE</creator><scope>EVB</scope></search><sort><creationdate>20230502</creationdate><title>New midazolam hydrochloride crystal form and preparation method thereof</title><author>WANG YING ; CHEN HONG ; ZENG XUEYAO ; HUANG CUI ; GU HUIKE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN116041351A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>WANG YING</creatorcontrib><creatorcontrib>CHEN HONG</creatorcontrib><creatorcontrib>ZENG XUEYAO</creatorcontrib><creatorcontrib>HUANG CUI</creatorcontrib><creatorcontrib>GU HUIKE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WANG YING</au><au>CHEN HONG</au><au>ZENG XUEYAO</au><au>HUANG CUI</au><au>GU HUIKE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>New midazolam hydrochloride crystal form and preparation method thereof</title><date>2023-05-02</date><risdate>2023</risdate><abstract>The invention relates to the field of medicine crystal forms, in particular to midazolam hydrochloride crystal forms III and VI and a preparation method thereof. The obtained crystal form III of the compound shown in the formula (I) has good physical stability and chemical stability, the used crystallization solvent is low in toxicity and residue, and the crystal form III is more suitable for large-scale production and amplification.
本申请涉及药物晶型领域，具体涉及盐酸咪达唑仑晶型Ⅲ、Ⅵ及其制备方法。本发明所得到的式(I)化合物的晶型Ⅲ具有较好的物理稳定性和化学稳定性，并且所用结晶溶剂低毒低残留，更适合于大规模生产放大。</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN116041351A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
| title | New midazolam hydrochloride crystal form and preparation method thereof |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T00%3A28%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WANG%20YING&rft.date=2023-05-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN116041351A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |